Close Menu

NEW YORK (360Dx) — Immucor said today that Health Canada has approved its NEO Iris mid- to high-volume automated immunohematology instrument.

According to Norcross, Georgia-based Immucor, the NEO Iris uses the company's Capture solid phase technology for antibody screening and identification, and can run up to 60 tests and screens per hour. It also integrates with Immucor's ImmuLink data management software to aggregate all serology and molecular test results to generate a single report with a complete donor or patient testing history.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.